Cemm - Forschungszentrum Fuer Molekulare Medizin GmbH

Cemm - Forschungszentrum Fuer Molekulare Medizin GmbH is a company in Wien, Austria that has taken part in 49 EU-funded projects since 2008, receiving €37.4M in EU funding and leading 34 as coordinator.

EU funding received€37.4M
EU projects49
As coordinator34
Running now10
First EU project2008
Latest project2027
CountryAustria
EU registration (PIC)999530293
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Cemm - Forschungszentrum Fuer Molekulare Medizin GmbH's own share of each project, not the project's full budget.

  • Horizon 2020€21.7M · 23 projects
  • Horizon Europe€8.8M · 11 projects
  • FP7 (2007 to 2013)€6.8M · 14 projects
  • Digital Europe Programme (DIGITAL)€129k · 1 project

Projects

49 EU-funded projects, newest first. Cemm - Forschungszentrum Fuer Molekulare Medizin GmbH led 34 of them as coordinator. Each links to the official record.

  • Solid-CARTCoordinator

    AI-in-the-loop in vivo screening and preclinical development of CRISPR-boosted CAR T cells for solid tumor therapy

    Horizon Europe · 2027–2032 · Project on CORDIS ↗

    €2.5Mtheir share
  • Da VinciAssociated partner

    Deep AI for VIenna Network of Computational Innovators

    Horizon Europe · 2027–2032 · Project on CORDIS ↗

  • Degron MinerCoordinator

    High-throughput discovery of degrons encoded by posttranslational modifications

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €230ktheir share
  • PhotoMelPartner

    Decoding Early-Life UVA and Skincare Additive Interactions Driving Melanoma Risk and Progression in Young Adults

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €1.0Mtheir share
  • QUANTAGECoordinator

    A quantitative tissue architecture framework to understand human aging and disease

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €1.5Mtheir share
  • Rewiring PRC2Coordinator

    Rewiring transcriptional regulation by the PRC2 complex using proximity inducing pharmacology

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €199ktheir share
  • GoEPartner

    Genome of Europe

    Digital Europe Programme (DIGITAL) · 2024–2028 · Project on the EU portal ↗

    €129ktheir share
  • ONCO-SPLICECoordinator

    Translating Tudor domain splicing inhibitors for oncological applications

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €150ktheir share
  • REWIRECoordinator

    Rewire the lymph node niche to instruct T cell immunity

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €1.5Mtheir share
  • T Cell FeedbackCoordinator

    T cell regulation by fed state bacterial metabolites

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €1.5Mtheir share
  • M-Y-croCoordinator

    Metabolism-YEATS-crosstalk: Elucidating metabolic dependencies of epigenetic YEATS action

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €184ktheir share
  • B-ALLelesAssociated partner

    High resolution dissection of non-coding determinants of disease

    Horizon Europe · 2022–2024 · Project on CORDIS ↗

  • EPI-CARTCoordinator

    Understanding and exploiting epigenetic regulation in CAR T cell therapy

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €2.0Mtheir share
  • REsolutionCoordinator

    Add medical genetic solutions to RESOLUTE (REsolution)

    Horizon 2020 · 2021–2023 · Project on CORDIS ↗

    €642ktheir share
  • TRAP-CARTCoordinator

    Tumor targeting through a TME-specific regulatory code and programmable CAR T cells

    Horizon 2020 · 2021–2023 · Project on CORDIS ↗

    €174ktheir share
  • AmmoniaVirCoordinator

    The impact of hyperammonemia in viral infection pathophysiology

    Horizon 2020 · 2021–2023 · Project on CORDIS ↗

    €174ktheir share
  • MapInDegradersCoordinator

    Closing the gap: studying non-obvious ligand induced degradation events

    Horizon 2020 · 2021–2023 · Project on CORDIS ↗

    €174ktheir share
  • DDREAMMPartner

    Dna Damage REsponse: Actionabilities, Maps and Mechanisms

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  • ImmunoSepPartner

    Personalized immunotherapy in sepsis: a precision medicine based approach

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €481ktheir share
  • Glue2DegradeCoordinator

    Therapeutic hijacking of E3 Ligases

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €1.3Mtheir share
  • HCA OrganoidCoordinator

    HCA|Organoid: Pilot action to establish a multi-tissue human organoid platform within the Human Cell Atlas as a booster of future disease-centric, mechanistic, and translational research

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €1.1Mtheir share
  • DohART-NETPartner

    Periconceptional Programming of Health Training Network

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €85ktheir share
  • SingleCellAICoordinator

    Deep-learning models of CRISPR-engineered cells define a rulebook of cellular transdifferentiation

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €186ktheir share
  • INITIATEPartner

    INnate-ImmunomeTabolIsm as Antiviral TargEt

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €264ktheir share
  • REAPPartner

    Repair of DNA lesions induced by platinum drugs

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €109ktheir share
  • ChemRASCoordinator

    Chemical probing of transcriptional RAS effectors

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €178ktheir share
  • ReSOLUTECoordinator

    Research empowerment on solute carriers (ReSOLUTE)

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €6.7Mtheir share
  • CHROMABOLISMCoordinator

    Chromatin-localized central metabolism regulating gene expression and cell identity

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €2.0Mtheir share
  • EpigenomeProgrammingCoordinator

    An experimental and bioinformatic toolbox for functional epigenomics and its application to epigenetically making and breaking a cancer cell

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €1.3Mtheir share
  • GameofGatesCoordinator

    Solute carrier proteins as the gates managing chemical access to cells

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €2.4Mtheir share
  • chemosCoordinator

    Chemical Hematology: breaking resistance of hematological malignancies through personalized drug trials

    Horizon 2020 · 2016–2017 · Project on CORDIS ↗

    €147ktheir share
  • SLIMCoordinator

    Synthetic Lethal Interactions with nucleophosMin 1

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

    €178ktheir share
  • CMILCoordinator

    Crosstalk of Metabolism and Inflammation

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €1.7Mtheir share
  • LIBRAPartner

    Leading Innovative measures to reach gender Balance in Research Activities

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €178ktheir share
  • DrugsUPCoordinator

    Solute carrier proteins and the uptake of cytotoxic approved drugs

    Horizon 2020 · 2015–2017 · Project on CORDIS ↗

    €178ktheir share
  • INNATEDNASENSORCoordinator

    A proteomic screen to identify cytoplasmic DNA sensor proteins mediating type I Interferon production

    FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

    €180ktheir share
  • IMMUNOCORECoordinator

    Inborn errors of innate immunity: systems genomics route to the core of the immune system

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €1.5Mtheir share
  • BERGCoordinator

    BERG – Biomedical Epigenomics Research Group

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €100ktheir share
  • GENES, DRUGS AND BREAST CANCERPartner

    Discovering Gene-Drug Interactions in Breast Cancer With a Systematic and Genetically Tractable Model

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €370ktheir share
  • AIRSHIPCoordinator

    Acute Inflammation Resolution by Soluble Human Inhibitory Protein

    FP7 (2007 to 2013) · 2012–2013 · Project on CORDIS ↗

    €150ktheir share
Show 9 more projects
  • NONCANATMCoordinator

    DNA damage response: ATMIN regulated non-canonical ATM activation

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €100ktheir share
  • EPICALCoordinator

    Systematic Identification and Validation of Epigenetic Cancer Lesions by Chemical Biology and Functional Genomics

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €100ktheir share
  • HEM_IDPartner

    HEMatopoietic cell IDentity : genetic and epigenetic regulation in normal and malignant hematopoiesis

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €255ktheir share
  • BLUEPRINTPartner

    A BLUEPRINT of Haematopoietic Epigenomes

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €654ktheir share
  • ASSETPartner

    ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours

    FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗

    €804ktheir share
  • EU-OPENSCREENPartner

    European Infrastructure of Open Screening Platforms for Chemical Biology

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €206ktheir share
  • I-FIVECoordinator

    Interferon-focused Innate Immunity Interactome and Inhibitome

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €2.0Mtheir share
  • TOLLICORCoordinator

    Dissecting pathogen recognition complexes of Toll-like receptors: hunting for new co-receptors and ligands

    FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗

    €168ktheir share
  • SMARTCoordinator

    Small Molecule Antagonists of chromatin modifying enzymes for Regulation of Transcription, proliferation and differentiation

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €230ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • antibiotics
  • artificial intelligence
  • autoimmune diseases
  • bacteriology
  • biochemistry
  • biomolecules
  • breast cancer
  • cell biology
  • cell signaling
  • cells technologies
  • colorectal cancer
  • computational science

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime